<table> 
<tbody>
<tr><th>Rank</th><th>Pathway</th><th>q-value</th></tr>
<tr><td>1</td><td>Signaling by plasma membrane FGFR1 fusions</td><td>4.0520928279040863e-66</td></tr>
<tr><td>2</td><td>FGFR1 mutant receptor activation</td><td>1.0550014120733216e-13</td></tr>
<tr><td>3</td><td>TRAIL  signaling</td><td>0.0013801315077690457</td></tr>
<tr><td>4</td><td>FGFR1b ligand binding and activation</td><td>0.0021104631137049933</td></tr>
<tr><td>5</td><td>FGFR1c and Klotho ligand binding and activation</td><td>0.009609754546044721</td></tr>
<tr><td>6</td><td>Repression of WNT target genes</td><td>0.1228612226522622</td></tr>
<tr><td>7</td><td>Protein repair</td><td>0.1265023784245519</td></tr>
<tr><td>8</td><td>Sodium/Calcium exchangers</td><td>0.2459565948945403</td></tr>
<tr><td>9</td><td>Activated NTRK2 signals through CDK5</td><td>0.2459565948945403</td></tr>
<tr><td>10</td><td>RUNX3 regulates WNT signaling</td><td>0.2459565948945403</td></tr>
<tr><td>11</td><td>RUNX3 regulates CDKN1A transcription</td><td>0.4026526215131901</td></tr>
<tr><td>12</td><td>Generation of second messenger molecules</td><td>0.4944453736984365</td></tr>
<tr><td>13</td><td>Mitochondrial Fatty Acid Beta-Oxidation</td><td>0.4944453736984365</td></tr>
<tr><td>14</td><td>PKA-mediated phosphorylation of CREB</td><td>0.4944453736984365</td></tr>
<tr><td>15</td><td>Platelet degranulation </td><td>0.4944453736984365</td></tr>
<tr><td>16</td><td>Phase 4 - resting membrane potential</td><td>0.4944453736984365</td></tr>
<tr><td>17</td><td>Processing of Intronless Pre-mRNAs</td><td>0.4944453736984365</td></tr>
<tr><td>18</td><td>Defects in biotin (Btn) metabolism</td><td>0.4944453736984365</td></tr>
<tr><td>19</td><td>Catecholamine biosynthesis</td><td>0.4944453736984365</td></tr>
<tr><td>20</td><td>Cytokine Signaling in Immune system</td><td>0.4944453736984365</td></tr>
<tr><td>21</td><td>MET activates STAT3</td><td>0.4944453736984365</td></tr>
<tr><td>22</td><td>Transmission across Chemical Synapses</td><td>0.4944453736984365</td></tr>
<tr><td>23</td><td>Cholesterol biosynthesis</td><td>0.4944453736984365</td></tr>
<tr><td>24</td><td>Post-translational protein modification</td><td>0.4944453736984365</td></tr>
<tr><td>25</td><td>Metabolism of nitric oxide: eNOS activation and regulation</td><td>0.4944453736984365</td></tr>
<tr><td>26</td><td>Keratan sulfate biosynthesis</td><td>0.4944453736984365</td></tr>
<tr><td>27</td><td>Loss of Nlp from mitotic centrosomes</td><td>0.4944453736984365</td></tr>
<tr><td>28</td><td>TYSND1 cleaves peroxisomal proteins</td><td>0.4944453736984365</td></tr>
<tr><td>29</td><td>Receptor Mediated Mitophagy</td><td>0.4944453736984365</td></tr>
<tr><td>30</td><td>Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)</td><td>0.4944453736984365</td></tr>
<tr><td>31</td><td>Loss of proteins required for interphase microtubule organization from the centrosome</td><td>0.4944453736984365</td></tr>
<tr><td>32</td><td>Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)</td><td>0.4944453736984365</td></tr>
<tr><td>33</td><td>Axon guidance</td><td>0.4944453736984365</td></tr>
<tr><td>34</td><td>FGFR3c ligand binding and activation</td><td>0.4944453736984365</td></tr>
<tr><td>35</td><td>Erythropoietin activates RAS</td><td>0.4944453736984365</td></tr>
<tr><td>36</td><td>2-LTR circle formation</td><td>0.4944453736984365</td></tr>
<tr><td>37</td><td>Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)</td><td>0.4944453736984365</td></tr>
<tr><td>38</td><td>Translesion synthesis by POLI</td><td>0.4944453736984365</td></tr>
<tr><td>39</td><td>Lysine catabolism</td><td>0.4944453736984365</td></tr>
<tr><td>40</td><td>DARPP-32 events</td><td>0.4944453736984365</td></tr>
<tr><td>41</td><td>HIV Life Cycle</td><td>0.4944453736984365</td></tr>
<tr><td>42</td><td>mRNA Editing: A to I Conversion</td><td>0.4944453736984365</td></tr>
<tr><td>43</td><td>Cohesin Loading onto Chromatin</td><td>0.4944453736984365</td></tr>
<tr><td>44</td><td>TLR3-mediated TICAM1-dependent programmed cell death</td><td>0.4944453736984365</td></tr>
<tr><td>45</td><td>Hydrolysis of LPC</td><td>0.4944453736984365</td></tr>
<tr><td>46</td><td>Glycogen storage disease type 0 (liver GYS2)</td><td>0.4944453736984365</td></tr>
<tr><td>47</td><td>C6 deamination of adenosine</td><td>0.4944453736984365</td></tr>
<tr><td>48</td><td>Synthesis of very long-chain fatty acyl-CoAs</td><td>0.4944453736984365</td></tr>
<tr><td>49</td><td>Sodium-coupled sulphate, di- and tri-carboxylate transporters</td><td>0.4944453736984365</td></tr>
<tr><td>50</td><td>Response of EIF2AK1 (HRI) to heme deficiency</td><td>0.4944453736984365</td></tr>
</tbody> 
</table>